Erlotinib Completed Phase 1 / 2 Trials for Rectal Carcinoma / Adenocarcinoma of the Rectum Treatment

IndicationsStatusPurposePhase
CompletedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs
NCT00543842Bevacizumab, Erlotinib, and Capecitabine for Locally Advanced Rectal Cancer